Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -27.27%-210M | 31.13%-396M | -70.10%-165M | -23.13%-575M | -410.53%-97M | 10.36%-467M | 77.38%-19M | 25.68%-521M | 68.54%-84M | -267.02%-701M |
| Profit adjustment | ||||||||||
| Investment loss (gain) | ---- | ---- | ---1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | 25.00%-3M | ---2M | ---4M | ---- | ---- | ---- | -93.33%1M | -94.12%1M | 250.00%15M |
| Impairment and provisions: | 130.23%99M | -93.23%18M | --43M | -3.62%266M | ---- | 300.00%276M | ---- | 228.57%69M | ---- | -61.11%21M |
| -Impairment of trade receivables (reversal) | ---- | -98.17%2M | ---- | 17.20%109M | ---- | 4,550.00%93M | ---- | -83.33%2M | ---- | 71.43%12M |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 600.00%63M | ---- | --9M |
| -Other impairments and provisions | 130.23%99M | -89.81%16M | --43M | -14.21%157M | ---- | 4,475.00%183M | ---- | --4M | ---- | ---- |
| Revaluation surplus: | ---- | -81.32%17M | ---- | 0.00%91M | -263.64%-36M | -67.15%91M | 1,200.00%22M | 201.09%277M | -101.68%-2M | 91.67%92M |
| -Fair value of investment properties (increase) | ---- | -80.68%17M | ---- | -3.30%88M | ---- | 1,616.67%91M | 500.00%8M | -107.14%-6M | -102.13%-2M | 68.00%84M |
| -Other fair value changes | ---- | ---- | ---- | --3M | -357.14%-36M | ---- | --14M | 3,437.50%283M | ---- | 500.00%8M |
| Asset sale loss (gain): | ---- | 755.56%118M | --2M | -125.00%-18M | ---- | -166.67%-8M | ---7M | -100.87%-3M | ---- | 511.90%346M |
| -Available for sale investment sale loss (gain) | ---- | --18M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | 77.78%-4M | --2M | -125.00%-18M | ---- | -700.00%-8M | ---- | ---1M | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---2M | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | --104M | ---- | ---- | ---- | ---- | ---7M | ---- | ---- | --346M |
| Depreciation and amortization: | -16.98%44M | 16.28%100M | 15.22%53M | 2.38%86M | 2.22%46M | -3.45%84M | 12.50%45M | 7.41%87M | 5.26%40M | -10.00%81M |
| -Depreciation | -16.98%44M | 16.28%100M | 15.22%53M | 6.17%86M | 9.52%46M | 1.25%81M | 13.51%42M | 8.11%80M | 5.71%37M | -10.84%74M |
| -Amortization of intangible assets | ---- | ---- | ---- | ---- | ---- | -57.14%3M | 0.00%3M | 0.00%7M | 0.00%3M | 0.00%7M |
| Financial expense | 0.00%57M | -6.45%116M | 7.55%57M | 58.97%124M | 65.63%53M | 21.88%78M | 0.00%32M | -15.79%64M | -27.27%32M | -19.15%76M |
| Special items | ---- | -92.00%2M | ---- | 327.27%25M | --34M | ---11M | ---- | ---- | ---- | ---4M |
| Operating profit before the change of operating capital | 23.08%-10M | -460.00%-28M | ---13M | -111.63%-5M | --0 | 265.38%43M | 661.54%73M | 64.86%-26M | 73.47%-13M | -7,500.00%-74M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -175.00%-6M | -142.86%-15M | -42.86%8M | 234.62%35M | 255.56%14M | 23.53%-26M | ---9M | -169.39%-34M | ---- | 169.01%49M |
| Accounts receivable (increase)decrease | -300.00%-4M | 85.71%-2M | 122.22%2M | -16.67%-14M | 30.77%-9M | -9.09%-12M | 62.86%-13M | -161.11%-11M | -284.21%-35M | -5.26%18M |
| Accounts payable increase (decrease) | -86.67%2M | -17.02%39M | -83.87%15M | 67.86%47M | 106.67%93M | -62.16%28M | 66.67%45M | 374.07%74M | 485.71%27M | -485.71%-27M |
| prepayments (increase)decrease | -146.67%-14M | -442.86%-24M | 1,400.00%30M | 111.48%7M | 103.92%2M | -274.29%-61M | -210.87%-51M | -16.67%35M | 4.55%46M | 4,300.00%42M |
| Special items for working capital changes | ---- | ---- | ---- | ---- | ---- | --103M | ---- | ---- | ---- | ---- |
| Cash from business operations | -176.19%-32M | -142.86%-30M | -58.00%42M | -6.67%70M | 122.22%100M | 97.37%75M | 80.00%45M | 375.00%38M | 108.33%25M | 117.78%8M |
| Hong Kong profits tax paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%-1M |
| Interest paid - operating | -1.85%-55M | -1.85%-110M | -8.00%-54M | -45.95%-108M | -61.29%-50M | -21.31%-74M | 0.00%-31M | 16.44%-61M | 26.19%-31M | 20.65%-73M |
| Net cash from operations | -625.00%-87M | -268.42%-140M | -124.00%-12M | -3,900.00%-38M | 257.14%50M | 104.35%1M | 333.33%14M | 65.15%-23M | 80.00%-6M | 52.17%-66M |
| Cash flow from investment activities | ||||||||||
| Decrease in deposits (increase) | --3M | ---- | ---- | 800.00%18M | ---- | -33.33%2M | ---- | -91.43%3M | -125.00%-11M | 181.40%35M |
| Sale of fixed assets | ---- | -66.67%2M | ---- | -14.29%6M | ---- | -80.56%7M | ---- | 100.00%36M | ---- | -56.10%18M |
| Purchase of fixed assets | -60.00%-8M | 85.29%-5M | 72.22%-5M | -61.90%-34M | -350.00%-18M | 50.00%-21M | ---4M | -200.00%-42M | ---- | 73.08%-14M |
| Sale of subsidiaries | --8M | 529.41%107M | ---- | -86.61%17M | ---- | 2,440.00%127M | ---- | --5M | ---- | ---- |
| Recovery of cash from investments | ---- | -35.14%48M | 115.38%28M | -67.54%74M | -35.00%13M | 7,500.00%228M | --20M | -25.00%3M | ---- | --4M |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --6M |
| Other items in the investment business | ---- | ---- | --2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | -88.00%3M | 87.65%152M | 600.00%25M | -76.38%81M | -131.25%-5M | 6,760.00%343M | 245.45%16M | -89.80%5M | -118.97%-11M | -14.04%49M |
| Net cash before financing | -746.15%-84M | -72.09%12M | -71.11%13M | -87.50%43M | 50.00%45M | 2,011.11%344M | 276.47%30M | -5.88%-18M | -160.71%-17M | 79.01%-17M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 39.29%234M | 253.54%449M | -16.42%168M | -71.96%127M | -5.63%201M | 19.84%453M | 16.39%213M | -53.51%378M | 50.00%183M | 3.04%813M |
| Refund | 9.50%-162M | -186.33%-398M | 14.35%-179M | 81.59%-139M | 21.72%-209M | -137.42%-755M | -97.78%-267M | 59.49%-318M | 3.57%-135M | -7.83%-785M |
| Issuing shares | ---- | ---- | ---- | --30M | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuance of bonds | ---- | ---- | ---- | ---- | ---- | ---- | --250M | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---13M | ---- | ---- | ---- | ---30M | ---241M | ---- | ---- | ---- |
| Net cash from financing operations | 241.67%51M | 53.33%-14M | 2.70%-36M | 91.85%-30M | 42.19%-37M | -1,462.96%-368M | -293.94%-64M | 550.00%27M | 283.33%33M | -124.00%-6M |
| Effect of rate | ---- | ---- | ---- | --1M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net Cash | -43.48%-33M | -115.38%-2M | -387.50%-23M | 154.17%13M | 123.53%8M | -366.67%-24M | -312.50%-34M | 139.13%9M | 60.00%16M | 58.93%-23M |
| Begining period cash | -4.26%45M | 42.42%47M | 42.42%47M | -42.11%33M | -42.11%33M | 18.75%57M | 18.75%57M | -32.39%48M | -32.39%48M | -44.09%71M |
| Cash at the end | -50.00%12M | -4.26%45M | -41.46%24M | 42.42%47M | 78.26%41M | -42.11%33M | -64.06%23M | 18.75%57M | -20.99%64M | -32.39%48M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | -64.06%23M | 18.75%57M | --64M | --48M |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | -64.06%23M | 18.75%57M | --64M | --48M |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | -- | -- | -- | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.